Paper523358
Pharmacokinetics of amphotericin B and flucytosine.
Polak A. Postgrad Med J, 1979. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics of amphotericin B and flucytosine. Papers, record 523358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/523358
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Cytosine | Major topic |
| Flucytosine | Major topic |
| Animals | |
| Drug Administration Schedule | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Models, Biological | |
| Rabbits | |
| Renal Dialysis |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 411419 | Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/411419 | PubMed |
| 2 | 646348 | Amphotericin B pharmacokinetics in humans. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/646348 | PubMed |
| 3 | 848928 | Bone marrow toxicity associated with 5-fluorocytosine therapy. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/848928 | PubMed |
| 4 | 5394441 | A pharmacologic guide to the clinical use of amphotericin B. | J Infect Dis | 1969 | https://conductscience.org/library/papers/5394441 | PubMed |
| 5 | 4791978 | 5-Fluorocytosine in the treatment of candidiasis with acute renal insufficiency: its kinetics during haemodialysis and peritoneal dialysis. | Biomedicine | 1973 | https://conductscience.org/library/papers/4791978 | PubMed |
| 6 | 4597703 | In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4597703 | PubMed |
| 7 | 4507092 | The kinetics of 5-fluorocytosine elimination in man. | Aust N Z J Med | 1972 | https://conductscience.org/library/papers/4507092 | PubMed |
| 8 | 4741211 | Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function. | Chemotherapy | 1973 | https://conductscience.org/library/papers/4741211 | PubMed |
| 9 | 4749757 | Use of 5-fluorocytosine in patients with impaired renal function. | Br Med J | 1973 | https://conductscience.org/library/papers/4749757 | PubMed |
| 10 | 4656396 | [Treatment of cryptococcal meningoencephalitis; value of 5-fluorocytosine]. | Rev Med Suisse Romande | 1972 | https://conductscience.org/library/papers/4656396 | PubMed |
| 11 | 5456013 | Amphotericin B serum concentrations during therapy. | Appl Microbiol | 1970 | https://conductscience.org/library/papers/5456013 | PubMed |
| 12 | 5819291 | Pharmacokinetics of intrathecally administered amphotericin B. | Am Rev Respir Dis | 1969 | https://conductscience.org/library/papers/5819291 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41661352 | CSF Leukocytes in Intracranial Infections: Diagnostic, Mechanistic, and Therapeutic Insights for Neurocritical Care. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41661352 | PubMed |
| 40381011 | Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40381011 | PubMed |
| 36448782 | Osteoarticular Mycoses. | Clin Microbiol Rev | 2022 | https://conductscience.org/library/papers/36448782 | PubMed |
| 36074014 | Paracoccidioidomycosis: Current Status and Future Trends. | Clin Microbiol Rev | 2022 | https://conductscience.org/library/papers/36074014 | PubMed |
| 35326807 | Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35326807 | PubMed |
| 33176744 | Along came a spider: an unusual organism identified in a peritoneal dialysis patient, a case report and literature review. | BMC Nephrol | 2020 | https://conductscience.org/library/papers/33176744 | PubMed |
| 31614505 | Antifungal Drugs: Special Problems Treating Central Nervous System Infections. | J Fungi (Basel) | 2019 | https://conductscience.org/library/papers/31614505 | PubMed |
| 31222254 | Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/31222254 | PubMed |
| 30725316 | In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid. | Infection | 2019 | https://conductscience.org/library/papers/30725316 | PubMed |
| 28702763 | Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. | Infection | 2017 | https://conductscience.org/library/papers/28702763 | PubMed |
| 24436013 | In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation. | Mycopathologia | 2014 | https://conductscience.org/library/papers/24436013 | PubMed |
| 24396137 | Tissue penetration of antifungal agents. | Clin Microbiol Rev | 2014 | https://conductscience.org/library/papers/24396137 | PubMed |
| 8261715 | Pharmacokinetic optimisation of oral antifungal therapy. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261715 | PubMed |
| 7492074 | Antifungal agents in neonatal systemic candidiasis. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7492074 | PubMed |
| 6973615 | Aspergillus granuloma of the trigeminal ganglion. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/6973615 | PubMed |
| 6695357 | Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin. | Thorax | 1984 | https://conductscience.org/library/papers/6695357 | PubMed |
| 6439112 | Quantitative extraction of amphotericin B from serum and its determination by high-pressure liquid chromatography. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6439112 | PubMed |
| 6301738 | Clinical pharmacokinetics of systemic antifungal drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6301738 | PubMed |
| 1744306 | Antibiotic levels in bronchial tree and in serum during selective digestive decontamination. | Intensive Care Med | 1991 | https://conductscience.org/library/papers/1744306 | PubMed |
| 1379913 | Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. | Drugs | 1992 | https://conductscience.org/library/papers/1379913 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/523358
GET https://conductscience.org/api/papers/v1/523358/authors